Anzeige
Mehr »
Login
Mittwoch, 01.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
93 Leser
Artikel bewerten:
(0)

The Ensign Group Reports Third Quarter 2009 Adjusted Earnings of $0.38 per Share / Conference Call and Webcast Scheduled for November 3, 2009 at 10:00 am PT

MISSION VIEJO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. , the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, today reported record results for the third quarter of fiscal year 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO) Financial Highlights for the Quarter Include: -- Total revenue was a record $132.9 million, up 14.3% compared to $116.3 million for the third quarter of 2008; -- Same-store skilled mix by revenue increased to 50.5% from 49.5% in the prior year quarter; -- The company's same-store average daily Medicare rate increased by 7.1% to $560 per patient day, an increase of $37 per patient day, as the company's overall patient base continued shifting to a higher acuity mix; -- Consolidated EBITDAR climbed 19.0% to $20.8 million, an increase of $3.3 million, with consolidated EBITDAR margins improving by 62 basis points to 15.6%, and same-store EBITDAR margins improving 80 basis points to 16.5%; and -- Consolidated net income for the quarter climbed 13.1% to $7.7 million, compared to $6.8 million the year before, with year-to-date net margins increasing to 6.0% from 5.7%. Operating Results

Ensign's President and Chief Executive Officer Christopher Christensen congratulated Ensign's facility leaders and their teams. "This solid third quarter has provided a great platform for the continuing expansion of our business," he said.

The company recently announced four facility acquisitions, bringing the total to eleven year to date. He added that the company is seeing compelling acquisition opportunities in several of its key markets, and expects to grow further in the near term. In addition, he noted that the opportunities for organic growth and improvement across the company's existing portfolio are outstanding, as local leaders continue to focus on business fundamentals and higher-acuity patients.

He also discussed the company's recent enhancement of its financial reporting methodologies. These details provide greater transparency into company operations, as it continues to layer in underperforming facilities and execute the long-term process of stabilizing and growing their operations.

Operational results are now being categorized by "same-store," referring to facilities that have been under the Ensign umbrella more than three full calendar years, "transitional," referring to facilities acquired from between one and three full calendar years ago, and "recently acquired," referring to facilities which joined the Ensign organization less than one full calendar year ago.

"This change reflects the sometimes-vast disparity between the operating metrics of different facilities as they go through the successive stages of the stabilization and growth process, which typically takes several years," he noted.

He also commented on the national healthcare debate, reductions in Medicare payments to skilled nursing facilities, and declines in state Medicaid rates. "Our operators have proven again this quarter that our unique operating model is well suited to, and even thrives in, uncertain operating environments," he observed. He added that company leaders "expect, based on our history and experience, to continue delivering solid returns and superior patient outcomes regardless of changes in reimbursement or regulation."

The company generated net cash from operations of $28.7 million in the nine months ended September 30, 2009. Net operating assets and liabilities grew by $8.0 million in the first nine months of 2009, which was primarily attributable to the growth in accounts receivable as revenues grew, particularly in recently-added facilities. Net cash used in investing activities during the first nine months was $45.4 million, which was primarily related to business acquisitions and purchases of property and equipment.

Consolidated EBITDA grew by $2.9 million for the quarter to $17.1 million, an increase of 20.4%; however, when adjusting for the one-time recovery of $660,000 related to the favorable settlement of an accrued contingent rent liability in the prior year quarter, the percentage increase in EBITDA was actually 26.2%. EBITDAR climbed 19.0% to $20.8 million from $17.5 million in the third quarter of 2008, an increase of $3.3 million.

Fully diluted GAAP earnings per share were $0.37 for the quarter, compared to $0.33 per share in the prior year. Excluding acquisition expenses, amortization of patient bases and the effect on net income of one lease expiration in the quarter, adjusted net income was $7.9 million or $0.38 per diluted share.

A discussion of the company's use of non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDAR and EBITDA, as well as a reconciliation of GAAP earnings per share and net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release.

More complete information is contained in the Company's 10-Q, which was filed with the SEC today and can be viewed on the Company's website at http://www.ensigngroup.net/.

2009 Guidance Reaffirmed

Management reaffirmed its previously-announced 2009 annual revenue guidance of $536 million to $541 million, and earnings guidance of $1.58 per share to $1.63 per share, for the year. The guidance is based on diluted weighted average common shares outstanding of 21.5 million and assumes, among other things, no additional acquisitions or dispositions beyond those made to date, and essentially flat overall reimbursement.

Management Changes

Ensign today announced that Gregory K. Stapley, its Vice President and General Counsel since 1999, has been named Executive Vice President of the Company effective as of November 2, 2009. He has been replaced by Beverly B. Wittekind as Vice President and General Counsel.

Ms. Wittekind has served as Ensign's Corporate Compliance Officer, and as Vice-President and General Counsel for Ensign Facility Services, Inc., its Service Center subsidiary, since 2002. Prior to joining Ensign Ms. Wittekind was with Vista Hospital Systems, a non-profit hospital system based in Corona, California, where she served as General Counsel, Chief Compliance Officer and Vice-President of Risk and Litigation Management. A 1989 graduate of the University of Notre Dame Law School, Ms. Wittekind began her career at the law firm of Snell & Wilmer, and was a partner at Doyle Winthrop Oberbillig & West, both in Phoenix, Arizona, where she specialized in the defense of healthcare providers in medical malpractice litigation.

In addition, Daniel H. Walker was named Assistant Secretary of the Company, also effective November 2, 2009. Mr. Walker has served as the Deputy General Counsel of Ensign Facility Services, Inc., and as the Company's Associate General Counsel for Securities, since 2007. Prior to joining Ensign, Mr. Walker was with the law firm of Lewis and Roca, LLP in Phoenix, Arizona, where he advised public and private companies on securities issues, mergers and acquisitions, and real estate and corporate transactions. Mr. Walker is a 2005 graduate of the J. Rueben Clark Law School at Brigham Young University.

Recent Highlights

The Company recently announced that it acquired four long-term care facilities in two separate transactions on October 1, 2009. The facilities include Golden Acres, a 22-acre campus in Dallas, Texas which has 264 skilled nursing beds, 222 of which are in private rooms, and a 39-unit independent living section. The Golden Acres acquisition also included a profitable and well-regarded hospice business, Custom Care Hospice. Although many Ensign facilities offer hospice services through third-party agencies, this is the first time Ensign has engaged in the hospice business itself.

Ensign also acquired three facilities in Utah: Castle Country Care Center, an 80-bed skilled nursing facility in Price, South Valley Care Center, a 116-bed skilled nursing facility in metropolitan Salt Lake City, and Rock Canyon Rehab & Care Center, a 200-bed skilled nursing facility in Provo. The Utah facilities were purchased with a combination of cash and seller financing.

Ensign also allowed the lease on one of its Arizona assisted living facilities to expire as of September 30, 2009, turning the operation over to a new tenant. An Ensign affiliate had operated Greenfields Assisted Living in Mesa, Arizona since 1999. Management has indicated that it expects the lease expiration to be slightly accretive going forward.

Management has reaffirmed that Ensign is actively seeking additional opportunities to acquire both well-performing and struggling long-term care operations across the Western United States. The four acquisitions and one lease expiration bring Ensign's growing portfolio to 73 facilities, 42 of which are Ensign-owned, with Ensign affiliates holding purchase options on nine of Ensign's 31 leased facilities.

Conference Call

A live webcast will be held on Tuesday, November 3, 2009, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) to discuss Ensign's third quarter financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors section of the Ensign website at http://investor.ensigngroup.net/. The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Pacific Time on Tuesday, November 10, 2009.

About Ensign(TM)

The Ensign Group, Inc.'s operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, hospice services, physical, occupational and speech therapies, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients at 73 care facilities in California, Arizona, Texas, Washington, Utah, Idaho and Colorado. Each of these facilities is operated by a separate, wholly-owned independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "Company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the Service Center or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net/.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management's current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company's business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve facilities, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of facilities; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of facilities; competition from other companies in the acquisition, development and operation of facilities; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its facilities if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company's periodic filings with the Securities and Exchange Commission, including its Form 10-Q, which was filed today, for a more complete discussion of the risks and other factors that could affect Ensign's business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Condensed Consolidated Statements of Income (in thousands, except per share data) ------------------------------------- Three Months Nine Months Ended Ended September 30, September 30, ------------- ------------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenue $132,924 $116,328 $395,387 $345,425 Expense: Cost of services (exclusive of facility rent and depreciation and amortization shown separately below) 107,264 94,297 316,753 278,364 Facility rent-cost of services 3,707 3,282 11,132 11,229 General and administrative expense 4,883 4,565 15,261 14,628 Depreciation and amortization 3,239 2,350 9,413 6,513 ----- ----- ----- ----- Total expenses 119,093 104,494 352,559 310,734 Income from operations 13,831 11,834 42,828 34,691 Other income (expense): Interest expense (1,249) (1,183) (3,718) (3,553) Interest income 81 239 220 1,094 ---- --- --- ----- Other expense, net (1,168) (944) (3,498) (2,459) Income before provision for income taxes 12,663 10,890 39,330 32,232 Provision for income taxes 4,977 4,093 15,537 12,582 ----- ----- ------ ------ Net income $7,686 $6,797 $23,793 $19,650 ====== ====== ======= ======= Net income per share: Basic $0.37 $0.33 $1.16 $0.96 ===== ===== ===== ===== Diluted $0.37 $0.33 $1.14 $0.95 ===== ===== ===== ===== Weighted average common shares outstanding: Basic 20,616 20,525 20,591 20,512 ====== ====== ====== ====== Diluted 20,928 20,777 20,910 20,667 ====== ====== ====== ====== Condensed Consolidated Balance Sheets (in thousands) September 30, December 31, 2009 2008 ------------- ------------ Assets Cash and cash equivalents $21,365 $41,326 Other current assets 68,397 63,122 ------ ------ Total current assets 89,762 104,448 Property and equipment, net 181,643 157,029 Other assets 50,445 35,424 ------ ------ Total assets $321,850 $296,901 ======== ======== Liabilities and stockholders' equity Current liabilities: Current liabilities, excluding current maturities of long-term debt $56,182 $56,575 Current maturities of long-term debt 1,122 1,062 ----- ----- Total current liabilities 57,304 57,637 Long-term debt-less current maturities 58,632 59,489 Other long-term liabilities 26,675 23,754 Total Stockholders' equity 179,239 156,021 ------- ------- Total liabilities and stockholders' equity $321,850 $296,901 ======== ======== Reconciliation of Net Income to EBITDAR (in thousands) -------------- Three Months Nine Months Ended Ended September 30, September 30, ------------ ------------- 2009 2008 2009 2008 ---- ---- ---- ---- Net income $7,686 $6,797 $23,793 $19,650 Interest expense, net 1,168 944 3,498 2,459 Provision for income taxes 4,977 4,093 15,537 12,582 Depreciation And amortization 3,239 2,350 9,413 6,513 ----- ----- ----- ----- EBITDA 17,070 14,184 52,241 41,204 Facility rent-cost of services 3,707 3,282 11,132 11,229 ----- ----- ------ ------ EBITDAR $20,777 $17,466 $63,373 $52,433 ======= ======= ======= ======= Adjusted Condensed Consolidated Statements of Income (In thousands, except per share data) ------------------------------------- Three Months Ended September 30, 2009 ------------------ Non- As GAAP Expiration As Reported Adj. of Lease (4) Adjusted -------- ---- ------------ -------- Revenue $132,924 $(496) $132,428 Expense: Cost of services (exclusive of facility rent and depreciation and amortization shown separately below) 107,264 (76) (1) (507) 106,681 Facility rent-cost of services 3,707 (137) 3,570 General and administrative expense 4,883 4,883 Depreciation and amortization 3,239 (13) (2) (111) 3,115 ----- -------- ----- ----- Total expenses 119,093 (89) (755) 118,249 Income from operations 13,831 89 259 14,179 Other income (expense): Interest expense (1,249) (1,249) Interest income 81 81 ---- ---- Other expense, net (1,168) (1,168) Income before provision for income taxes 12,663 89 259 13,011 Provision for income taxes 4,977 35 (3) 103 5,115 ----- ------ --- ----- Net income $7,686 54 156 $7,896 ====== == === ====== Net income per share: Basic $0.37 $0.38 ===== ===== Diluted $0.37 $0.38 ===== ===== Weighted average common shares outstanding: Basic 20,616 20,616 ====== ====== Diluted 20,928 20,928 ====== ====== Nine Months Ended ----------------- September 30, 2009 ------------------ Non- As GAAP Expiration As Reported Adj. of Lease (4) Adjusted -------- ---- ------------ -------- Revenue $395,387 $(1,412) $393,975 Expense: Cost of services (exclusive of facility rent and depreciation and amortization shown separately below) 316,753 (177) (1) (1,185) 315,391 Facility rent-cost of services 11,132 (416) 10,716 General and administrative expense 15,261 15,261 Depreciation and amortization 9,413 (388) (2) (153) 8,872 ----- --------- ----- ----- Total expenses 352,559 (565) (1,754) 350,240 Income from operations 42,828 565 342 43,735 Other income (expense): Interest expense (3,718) (3,718) Interest income 220 220 --- --- Other expense, net (3,498) (3,498) Income before provision for income taxes 39,330 565 342 40,237 Provision for income taxes 15,537 223 (3) 136 15,896 ------ ------- --- ------ Net income $23,793 342 206 $24,341 ======= === === ======= Net income per share: Basic $1.16 $1.18 ===== ===== Diluted $1.14 $1.16 ===== ===== Weighted average common shares outstanding: Basic 20,591 20,591 ====== ====== Diluted 20,910 20,910 ====== ======

(1) Represents acquisition-related costs expensed, which were previously capitalizable during 2008.

(2) Represents amortization costs related to patient base intangible assets acquired. Patient base intangible assets are amortized over a period of four to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date.

(3) Represent s the tax impact of the acquisition costs and patient base non-GAAP adjustments represented in entries (1) and (2).

(4) Represents the impact on net income, including tax effect, of the expiration of the Company's lease at one of its assisted living facilities in Arizona.

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) provisions for income taxes, and (c) depreciation and amortization. EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, and (d) facility rent-cost of services. The Company believes that the presentation of EBITDA and EBITDAR provides important supplemental information to management and investors to evaluate the Company's operating performance. The Company believes disclosure of adjusted non-GAAP net income and non-GAAP diluted earnings per share has economic substance because the excluded expenses are infrequent in nature and are variable in nature, or do not represent current cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the Company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the Company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the Company's Report on Form 10-Q filed today with the SEC. The Form 10-Q is available on the SEC's website at http://www.sec.gov/ or under the "Financial Information" link of the Investor Relations section on Ensign's website.

Photo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO
http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com

The Ensign Group, Inc.

CONTACT: Robert East of Westwicke Partners LLC, +1-443-213-0500,
bob.east@westwickepartners.com, for The Ensign Group, Inc.; or Gregory
Stapley, Investor/Media Relations of The Ensign Group, Inc., +1-949-487-9500,
ir@ensigngroup.net

Web Site: http://www.ensigngroup.net/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.